Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I C van Gelder

Showing results (11-20 of 106) with videos related to

Pageof 11
Sort By:
Journal of Cardiovascular Electrophysiology|March 25, 1999
Left ventricular ischemia due to coronary stenosis as an unexpected treatable cause of paroxysmal atrial fibrillationB A Schoonderwoerd, I C Van Gelder, H J Crijns
The American Journal of Cardiology|December 1, 1988
Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatmentH J Crijns, I C van Gelder, K I Lie
European Heart Journal|September 11, 2001
Recurrence of atrial fibrillation and the need for new definitionsH J Crijns, T van Noord, I C van Gelder
Circulation|September 12, 2001
Pericardioversion dofetilide does not suppress immediate and subacute recurrences of persistent atrial fibrillationT Van Noord, I C Van Gelder, H J Crijns
European Heart Journal|April 1, 1994
Benefits and risks of antiarrhythmic drug therapy after DC electrical cardioversion of atrial fibrillation or flutterH J Crijns, I C van Gelder, K I Lie
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|September 8, 2016
Non vitamin K anticoagulation drugs will win the raceI C Van Gelder, R R De With, M Rienstra
Nederlands Tijdschrift Voor Geneeskunde|May 18, 2017
[Cardiac resynchronization therapy: who is a candidate and who is not?]M Kloosterman, A H Maass, M Rienstra, et al.
Heart (British Cardiac Society)|September 17, 2002
Treatment of atrial fibrillationY Blaauw, I C Van Gelder, H J G M Crijns
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
Alternating bundle branch blockL J Wagenaar, I C van Gelder, D J van Veldhuisen
Lancet (London, England)|August 25, 1999
QT lengthening and life-threatening arrhythmias associated with fexofenadineY M Pinto, I C van Gelder, M Heeringa, et al.
Pageof 11

Showing results (11-20 of 106) with videos related to

Sort By:
Pageof 11
Journal of Cardiovascular Electrophysiology|March 25, 1999
Left ventricular ischemia due to coronary stenosis as an unexpected treatable cause of paroxysmal atrial fibrillationB A Schoonderwoerd, I C Van Gelder, H J Crijns
The American Journal of Cardiology|December 1, 1988
Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatmentH J Crijns, I C van Gelder, K I Lie
European Heart Journal|September 11, 2001
Recurrence of atrial fibrillation and the need for new definitionsH J Crijns, T van Noord, I C van Gelder
Circulation|September 12, 2001
Pericardioversion dofetilide does not suppress immediate and subacute recurrences of persistent atrial fibrillationT Van Noord, I C Van Gelder, H J Crijns
European Heart Journal|April 1, 1994
Benefits and risks of antiarrhythmic drug therapy after DC electrical cardioversion of atrial fibrillation or flutterH J Crijns, I C van Gelder, K I Lie
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|September 8, 2016
Non vitamin K anticoagulation drugs will win the raceI C Van Gelder, R R De With, M Rienstra
Nederlands Tijdschrift Voor Geneeskunde|May 18, 2017
[Cardiac resynchronization therapy: who is a candidate and who is not?]M Kloosterman, A H Maass, M Rienstra, et al.
Heart (British Cardiac Society)|September 17, 2002
Treatment of atrial fibrillationY Blaauw, I C Van Gelder, H J G M Crijns
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
Alternating bundle branch blockL J Wagenaar, I C van Gelder, D J van Veldhuisen
Lancet (London, England)|August 25, 1999
QT lengthening and life-threatening arrhythmias associated with fexofenadineY M Pinto, I C van Gelder, M Heeringa, et al.
Pageof 11